Role of Genetic Polymorphisms in the Development of Nonalcoholic Fatty Liver Disease (NAFLD) and Steatohepatitis (NASH)

被引：0
|
作者：
Bril, Fernando [1 ,2 ]
Kawaguchi-Suzuki, Marina [1 ]
Frye, Reginald [1 ]
Sanchez, Paola Portillo [1 ,2 ]
Maximos, Maryann [1 ]
Lai, Song [3 ]
Hardies, Jean [4 ]
Tio, Fermin [4 ]
Cusi, Kenneth [1 ,2 ]
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Malcom Randall VA Med Ctr, Gainesville, FL USA
[3] Univ Florida, CTSI Human Imaging Core McKnight Brain Inst, Gainesville, FL USA
[4] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
799
引用
下载
收藏
页码：585A / 585A
页数：1
相关论文
共 50 条
  • [31] Therapeutic Effects of microRNAs on Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): A Systematic Review and Meta-Analysis
    Zhu, Yuezhi
    Tan, Jen Kit
    Wong, Sok Kuan
    Goon, Jo Aan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [32] Role of Genetic Polymorphisms on the Improvement of Liver Histology after Pioglitazone Treatment in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
    Kawaguchi-Suzuki, Marina
    Bril, Fernando
    Cusi, Kenneth
    Langaee, Taimour
    Gong, Yan
    Frye, Reginald
    HEPATOLOGY, 2014, 60 : 591A - 591A
  • [33] The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Konstantin Kazankov
    Simon Mark Dahl Jørgensen
    Karen Louise Thomsen
    Holger Jon Møller
    Hendrik Vilstrup
    Jacob George
    Detlef Schuppan
    Henning Grønbæk
    Nature Reviews Gastroenterology & Hepatology, 2019, 16 : 145 - 159
  • [34] The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Kazankov, Konstantin
    Jorgensen, Simon Mark Dahl
    Thomsen, Karen Louise
    Moller, Holger Jon
    Vilstrup, Hendrik
    George, Jacob
    Schuppan, Detlef
    Gronbaek, Henning
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (03) : 145 - 159
  • [35] Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain
    Romero-Gomez, Manuel
    Kachru, Nandita
    Zamorano, Meritxell Ascanio
    Darba, Josep
    Shreay, Sanatan
    MEDICINE, 2020, 99 (50) : E23506
  • [36] Non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in living-donor liver transplantation (LDLTX)
    Yamamoto, K
    Takada, Y
    Fujimoto, Y
    Haga, H
    Egawa, H
    Tanaka, K
    LIVER TRANSPLANTATION, 2004, 10 (06) : C29 - C29
  • [37] Galectin-3 (Gal-3) Expression in Relation to Fibrosis in Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
    Goodman, Zachary D.
    Mulder, Christopher
    Bolduc, Caroline A.
    Raines, Matthew F.
    Cebe, Katherine M.
    Alaparthi, Lakshmi
    Monge, Fanny
    Traber, Peter G.
    Harrison, Stephen A.
    GASTROENTEROLOGY, 2014, 146 (05) : S951 - S951
  • [38] Nonalcoholic fatty liver disease in obese adolescents: the role of genetic polymorphisms
    Abenavoli, Ludovico
    Boccuto, Luigi
    HEPATOBILIARY SURGERY AND NUTRITION, 2019, 8 (02) : 179 - 180
  • [39] The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Shouhed, Daniel
    Steggerda, Justin
    Burch, Miguel
    Noureddin, Mazen
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (09) : 797 - 811
  • [40] The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Cha J.-Y.
    Kim D.-H.
    Chun K.-H.
    Laboratory Animal Research, 2018, 34 (4) : 133 - 139
12345